Production Assistance for Cellular Therapies


City of Hope’s Center for Biomedicine & Genetics (CBG) has been selected as one of the 5 Cell Processing Facilities offering translational services and cell product manufacturing for pre-clinical studies to investigators at no charge under the National Heart, Lung, and Blood Institute-funded Production Assistance for Cellular Therapies (PACT) program. 

September 22, 2016 - City of Hope to Manufacture Novel Cell Therapies

The 5 PACT Cell Processing Facilities & Coordinating Centers are:

  1. University of Minnesota Molecular and Cellular Therapeutics (MCT), HHSN268201600014I
  2. Center for Cell and Gene Therapy (CAGT), Baylor College of Medicine, HHSN268201600015I
  3. Center for Biomedicine and Genetics, City of Hope, HHSN268201600011I
  4. Interdisciplinary Stem Cell Institute Cellular Manufacturing Program (ISCI-CMP), Miller School of Medicine, University of Miami, HHSN268201600012I
  5. Moffit Cancer Center and Research Institute, HSN268201600013I
  6. Coordinating Center-The Emmes Corporation, HHSN268201600020C

PACT's objective is to promote the advancement of cellular therapy research in the areas of regeneration of damaged/diseased tissues, organs, and biologic systems, and targeted treatments for serious diseases without effective therapies in support of the NHLBI's program areas of interest:  cardiovascular, pulmonary, blood, hematopoietic, and stem cell disorders.  For qualifying areas of interest, please see the PACT Application: Scope Criteria located at  

The PACT program at City of Hope can provide:

  1. Neural stem cells
  2. Bacterial products
  3. hESC products
  4. iPSC products
  5. Islet cells
  6. Transduced T cells
  7. Monoclonal antibodies
  8. Baculovirus proteins
  9. Plasmid DNA
  10. Lentivirus
  11. Adenovirus
  12. Tranduced HPC
  13. Vaccinia virus
  14. Oncolytic VSV